- Home
- PSTL vs OLMA Comparison
PSTL vs OLMA Comparison
Compare PSTL & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTL
- OLMA
- Stock Information
- Founded
- PSTL 2018
- OLMA 2006
- Country
- PSTL United States
- OLMA United States
- Employees
- PSTL N/A
- OLMA N/A
- Industry
- PSTL Real Estate Investment Trusts
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- PSTL Real Estate
- OLMA Health Care
- Exchange
- PSTL Nasdaq
- OLMA Nasdaq
- Market Cap
- PSTL 329.8M
- OLMA 299.7M
- IPO Year
- PSTL 2019
- OLMA 2020
- Fundamental
- Price
- PSTL $14.56
- OLMA $5.51
- Analyst Decision
- PSTL Strong Buy
- OLMA Strong Buy
- Analyst Count
- PSTL 1
- OLMA 5
- Target Price
- PSTL $17.75
- OLMA $24.00
- AVG Volume (30 Days)
- PSTL 135.5K
- OLMA 538.5K
- Earning Date
- PSTL 08-04-2025
- OLMA 08-11-2025
- Dividend Yield
- PSTL 6.66%
- OLMA N/A
- EPS Growth
- PSTL 344.13
- OLMA N/A
- EPS
- PSTL 0.39
- OLMA N/A
- Revenue
- PSTL $86,535,000.00
- OLMA N/A
- Revenue This Year
- PSTL $19.86
- OLMA N/A
- Revenue Next Year
- PSTL $10.14
- OLMA N/A
- P/E Ratio
- PSTL $37.61
- OLMA N/A
- Revenue Growth
- PSTL 26.43
- OLMA N/A
- 52 Week Low
- PSTL $12.26
- OLMA $2.86
- 52 Week High
- PSTL $15.42
- OLMA $13.93
- Technical
- Relative Strength Index (RSI)
- PSTL 51.11
- OLMA 63.06
- Support Level
- PSTL $14.29
- OLMA $4.47
- Resistance Level
- PSTL $14.88
- OLMA $5.58
- Average True Range (ATR)
- PSTL 0.30
- OLMA 0.35
- MACD
- PSTL 0.04
- OLMA 0.03
- Stochastic Oscillator
- PSTL 75.19
- OLMA 87.39
About PSTL Postal Realty Trust Inc.
Postal Realty Trust Inc is an internally managed real estate corporation that owns and manages properties leased to the United States Postal Service, or the USPS. Its objective is to create stockholder value by generating risk-adjusted returns through expanding its portfolio of owned and managed postal properties leased to the USPS. The majority of the revenue is generated from the rental income received.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.